ltiple births. Following a referral from a pediatrician, neurosurgeon, or other specialist, infants with plagiocephaly or a related condition, such as brachycephaly or scaphocephaly, are evaluated by a practitioner at the STAR Cranial Center of Excellence, scanned with the state-of-the-art STARscanner, and treated when necessary with a STARband cranial remolding orthosis. In cases where an infant's plagiocephaly is considered mild, or if the practitioner believes the infant is young enough, the practitioner may recommend that the patient be rescanned after several weeks of repositioning efforts to see if the infant's head shape improves without STARband treatment.
STARband cranial remolding helmets, also commonly referred to as a cranial remolding orthoses or headbands, are worn 23 hours per day for three to six months, channeling head growth by applying constant, gentle contact on protruding areas of the head, while leaving room for growth in flattened areas. The helmet is adjusted every two to three weeks to account for growth and head shape changes. Infants adapt well to the STARband.
The STAR Cranial Center of Excellence exclusively uses the STARscanner system, which scans a child's head in less than two seconds. It is faster, cleaner, more accurate, and less stressful for infants than the traditional plaster casting technique. The STARscanner provides detailed measurements and objective head shape data that is helpful for the patient's family, referring physician, and practitioner to review when determining the need for treatment. The STARscanner also documents head shape changes before, during, and after treatment.
Early recognition of head shape abnormalities is critical for optimal treatment results. Treatment for plagiocephaly is most effective if begun at four to six months of age. Some physicians believe that lack of treatment can lead to developmental delays, visual impairment and misaligned
'/>"/>
SOURCE Orthomerica Products, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
CONCERTA(R) (methylphenidate HCl) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS2.
CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS3.
Nurses Facing National Shortage Turn to Mobile Technology to Support Patient Care 4.
Choco Milk Initiates Adventure-Filled Mobile Tour That Teaches Children Nutrition Awareness5.
Dont Miss Twinlabs(R) 2009 Mobile Beach Bash Grand Finale Celebration Labor Day Weekend6.
Mom & Baby Mobile Health Centers Have Become Primary Care Providers Along the Gulf Coast7.
Mobile MedCheck Brings Back House Calls 8.
Lagan Increases Productivity of Case Management Workers in the Field; Saves Time and Money for Human Services Agencies with Lagan Mobile(TM)9.
Ingenious Meds IM Quality(TM) Solution Goes Mobile10.
Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer11.
ASAP Systems Introduces Mobile RFID Technology for its Passport Assets Application Enabling Increase Asset Management Flexibility